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Cross-reactions between mammalian transplantation antigens and certain 
bacterial structures have been postulated on the basis of various observations. 
In a  series of convincing experiments, Rapaport and Chase (1-3)  have clearly 
demonstrated that skin graft sensitization may be achieved with streptococcal 
membrane antigens in a variety of different species, such as guinea pigs, mice, 
rats,  or rabbits  (4). However,  it has been difficult to determine from these 
experiments whether the observed sensitization was related to antigenic simi- 
larities between the bacterial membranes and organ-related transplantation 
antigens or to products of the major histocompatibility complex (HLA) itself. 
Therefore, the intriguing question remained: namely, did cross-reactivity be- 
tween streptococcal antigens and mammalian tissues extend to the individual 
HLA antigens? The only direct evidence for this possibility has come from HLA 
cytotoxicity inhibition studies with bacterial structures. In spite of substantial 
efforts in this direction (5), such studies have remained ambiguous. For exam- 
ple,  nonserological inhibitory mechanisms have been suggested (6)  while in 
other experiments specific antibody other than anti-HLA was not strictly ex- 
cluded  (7). In view of these discrepancies,  the  true  nature of the  observed 
inhibition phenomena had  to  be  re-examined before  any  conclusions about 
antigenic relationships between histocompatibility antigens and bacterial struc- 
tures could be drawn. For this purpose, the HLA studies were repeated with the 
proper controls. The present report indicates that there is no evidence for a 
serological cross-reaction between streptococcal membrane antigens and the 
HLA antigens. Rather, the observed inhibitory effect appears to be based on a 
nonspecific anticomplementary activity of these bacterial structures. 
Materials and Methods 
Bacterial Strains.  Throughout these experiments, we used two strains of streptococci from the 
collection of Dr.  R.  C.  Lancefield.  Strain  $43/192/2  is a  Group A  serological type 6  originally 
isolated in 1919 from patient No. 43 during the epidemic outbreak at Fort Houston, San Antonio, 
* Nomenclature according to WHO-IUIS Terminology Committee Nomenclature for Factors of 
the HLA Systems. 1976. Transplant. Proc. 8:109. 
$ This work was carried out in partial fulfillment for the requirements of a  Ph.D.  (J. W. T.), 
supported by a Rockefeller University fellowship and private funding. 
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Texas, and has been cultured through 192 mouse passages. The second strain, A932, is a Group D 
streptococcus  originally isolated from neonatal blood in 1967 during an outbreak of streptococcal 
infections in the nursery of Lincoln Hospital, New  York.  The two  strains were kindly made 
available in lyophilized form by Dr. R. C. Lancefield, The Rockefeller University, New York. 
Preparation  of Media and Growth.  Lyophilized streptococci were resnspended in 5 ml of Tedd- 
Hewitt broth (8) to which 0.2 ml of defibrinated normal rabbit blood has been added.  After an 
incubation  of 24 h at 37°C, the microorganism  was transferred to 30 ml of Tedd-Hewitt broth, then 
250 ml, and finally, 20 liters of final medium (9). The final medium was prepared as follows: for 
each 20 liters of medium, 600 g of yeast extract (Difco Laboratories, Detroit, Mich.) and 60 g of 
glucose were mixed with 600 cm  ~  of H~O and heated to 80~C for 15 min with constant stirring. 1 cm  3 
of an antifoaming  agent (Dow Coming antifoam compound; Dow Coming Corp., Midland, Mich.) 
was also added to prevent excessive foaming. After cooling, the contents were placed in dialysis 
sacks (catalogue no. 8-667C; Fisher Scientific Co., Pittsburgh, Pa.). Care was taken not to fill the 
dialysis sacks beyond half volume. The sacks were dialyzed against two changes of 10 liters of 
distilled H20 at 4°C. The dialysate material was adjusted to 20 liters and filtered through an FP- 
1610 Selas-type filter candle, porcelain, 02 porosity (SGA Scientific, Inc., Bloomfield,  N.  J.). 
Purity of the organism was checked at each step of the procedure by streaking the inoculum on 
sheep bleed agar plates. After 18 h of incubation at 37°C, the cells were harvested in a Sharples 
continuous flow centrifuge (Sharpies-Stokes Div., Penwalt Corp., Warminster, Pa.). 
Preparation  of  Pure Membranes.  The cell pellet was washed once in 300 ml phosphate-buffered 
saline (PBS) 1  and then taken up in 0.05 M phosphate buffer, pH 6.1, containing  4% NaC1 and 0.005 
M EDTA with activated phage-associated lysin and incubated at 37°C  for 2 h (10). This enzyme, an 
L-alanine-amidase, breaks the peptide bridge responsible for  cress-linking the peptidogiycan 
moiety, leaving the fragile protoplasts intact. The pretoplasts were centrifuged down at 4,000 g, 
washed three times in isotonic saline, and resusponded in 0.02 M phosphate buffer, pH 7.3, 
containing 0.02% NaCI and 0.1% MgCI2 6H20 with 20 mg DNase and RNase per liter,  and 
incubated for  i  h at  37°C.  This  hypotonic buffer  ruptured  the  protoplasts,  permitting release  of  the 
intracellular  contents.  The naked membranes were separated from the cytoplasmic components 
with  high speed  centrifugation  at  27,000  g and  again incubated  with  the  RNase and  DNase buffer. 
The membrane pellet  was washed five  times  in  200  ml of  PBS and followed  by  an  equal  number of 
washes in distilled  water. The final  wash in distilled  H~O was followed by resuspension of  the 
membranes in 200  ml of  distilled  water and an aliquot  removed and lyophilized  to  determine the 
concentration of  the membranes. The suspension was frozen in aliquots  at -70°C until  use. 
Special  concern  was given  to  the  technique  of  resuspension during  the  washes. This  seems to  be 
an important detail  to achieve pure preparations, since  the membrane  pellets  have a strong 
tendency to  adhere  to  each  other during  centrifugation  procedures. For  this  purpose, an  ultrasonic 
water  bath (Heat  Systems-Ultrasonics, Inc.,  Plainview, N. Y.)  was  employed. The water  level  was 
carefully  adjusted so that maximum  activity  occurred in a single central spot.  The membrane 
suspension was placed in  the  sonic  field  for  5-20  rain  to  achieve a homogeneous suspension during 
each wash. 
The enzymatic separation of  wall  and membrane could not  be  used  for  the  Group D membranes 
since  the  phage-associated lysin  is  restricted  in  its  specificity.  Therefore, the  Group D streptococci 
were mechanically disrupted using a Braun disintegrator (B. Braun Instruments,  San Mateo, 
Calif.)  (11).  The disruption  was monitored by gram stain  which showed loss  of  the gram-positive 
staining  in 90% of  the  cells  after  i h of  treatment in the  disintegrator.  After differential  centrifu- 
gation to  isolate  the  cell  walls and membranes, both  materials were treated  with RNase buffers  as 
described above. 
Because of difficulties  inherent in separating cellular  components completely by mechanical 
means, the  resulting  membrane preparation was  not  as  pure as  the  enzyme-induced material.  The 
biochemical distribution  of  rharnnose according to  Dische and Shettles (12)  provides evidence for 
the degree of  purity: 
A  D 
content of  rhamnose (%)  0.5  4.1-5.9 
contamination with wall (%)  1.9  ? 
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Rhamnose is the major sugar moiety and composes 27% of the weight of the cell wall of Group A 
streptococci; it is not present in pure membrane preparations  (13) in Groups A and C. 
The lyophilized membranes were used. in various modifications to absorb out HL-A antisera. 
After assessment of the dry weight, membranes were suspended in serum-free McCoy's medium 
(catalogue no. 166-O; Grand Island Biological Co., Grand Island, N. Y.). To achieve homogeneous 
dispersion, this solution was sonicated for 30 s while submerged in an ice bath.  A  Sonifier Cell 
Disruptor,  Model W185 (Heat Systems-Ultrasonics, Inc.) with a regular probe was used for this 
purpose, and the output control was set on position 5. The milky suspension was mixed with an 
equal volume of McCoy's medium containing 30% fetal calf serum.  Further dilutions were made 
with 15% serum-containing McCoy's medium. 
These suspensions were incubated immediately with the specific antisera to be tested. Immedi- 
ate incubation was felt to be crucial for the absorption studies in order to prevent reaggregation of 
membrane fragments which might mask important antigenic determinants. Thus, the delay from 
sonication to incubation with the HL-A antisera never exceeded 2 min. 
Tissue Typing.  Tissue typing was carried out in Terasaki trays (14), and for special studies the 
Scandinavian method was applied in parallel (15). Briefly, the following quantities of materials 
were used: 1 pl of specific HLA antiserum of a given dilution was introduced into the microwell 
with a Hamilton syringe (Hamilton Co., Reno, Nev.). If an inhibition protocol was followed, then 1 
/~l  of just-sonicated  membranes  was  added  into  this  same  well as  the  second  step.  After an 
incubation of 30 min, 1/~l of the target cells containing 2 ×  106 lymphocytes/ml was added to the 
tray. After an additional incubation at 37°C for 30 min, 5/~1 of complement (C) was added.  The 
amount of membranes used is given as the final concentration in the total vol of the microwell 
which is 8/~1. After an additional 1 h at room temperature, 3 ftl of an aqueous solution of 5% eosin 
Y (Tetrabromofluoresceinsodium; Fisher Scientific, Inc.) were added, and the percent of dead cells 
estimated under the microscope. Further modifications of the procedure were outlined with the 
corresponding results. 
HLA Antisera.  The  panel  of antisera  of the  Tissue  Typing  Laboratory,  Toronto  Western 
Hospital, Toronto, Canada, was screened for four representative specificities of the major Cpub- 
lic") families of histocompatibility antigens.  These sera were carefully selected in order to avoid 
cross-reactivity within the families of HLA antisera (Table D. The selected antisera detected the 
following HLA antigens: A1 and A2 from the first series, and B7 and B12 from the second series. To 
confirm that  any specific results would be due to the HLA antibody and not to oher unknown 
constituents  of a  given antiserum,  three  different sources with identical A2 specificities were 
compared. One of these antisera was a purified myeloma protein of the IgG2 class with functional 
activity specific to the A2 antigen (16).  The activity, strength,  and optimal titers of the antisera 
used in these studies were determined in preliminary trials and will be indicated for each set of 
experiments. 
Complement.  Blood was obtained from 3-wk-old rabbits; the serum was separated and stored 
away in aliquots at -70°C. Undiluted serum freshly thawed was used in all experiments. 
Target Cells,  Lymphocytes from three different donors were employed and represented one or 
more of the histocompatibility antigens detected by the antisera.  Peripheral blood was freshly 
collected and defibrinated with glass beads. The lymphocytes were then selectively harvested by 
floating on  a  Ficoll-Hypaque solution  (1.080  g/ml)  (17).  If the  number  of polymorphonuclear 
leukocytes  in  the  mononuclear  layer was  too high,  further  purification  was  achieved by the 
addition of carbonyl iron to the cells (18) followed by magnetic removal of those polymorphonu- 
clear neutrophils which had ingested the carbonyl iron. To avoid any peculiarities of the donor, 
various donor sources representative for identical specificities were used in all experiments. 
Results 
Because of the complexity of the cytotoxic assay system itself, it was decided 
to test the individual components of the system in a series of experiments. The 
results of these experiments will be reported under separate headings, together 
with the additional technical details involved in each experiment. 
Confirmation of Inhibitory Effect.  The purpose of these experiments was to 
confirm the findings of previous authors, namely,  that streptococcal  antigens 1344  RE-EVALUATION OF  HLA  CYTOTOXICITY INHIBITION 
TABLE I 
Partial List of HLA Antigens Belonging to the Two Segregant 
Series A  and B 
First  Second 
t A2*  B5  A28  ~BW35 
A9  ~B12" 
~B13  f 
[AI*  [ BW40} 
B7* 
~ B27 
~AW33 
BW15 
Braces  refer  to  observed cross-reactions  between  individual  HLA spec- 
ificities. 
* Refers to  the HLA specificities  selected  for  inhibition  studies. 
can indeed inhibit  the cytotoxic  effect  of HLA  antisera.  Thus, the standard 
procedure of these earlier  reports  was followed as closely  as possible  (5, 7). 
Briefly,  the undiluted HLA antisera  were distributed  into  the Terasaki wells 
(14),  as  well  as  Scandinavian  trays  (15).  Then, the  freshly  sonicated  membranes 
of Group A  and Group D  streptococci  were added to the wells  at different 
concentrations.  After  incubation  of  30 rnin  at  37°C,  the  target  cells  were added, 
followed  by the addition  of  C as described  in  previous sections. 
The results  are summarized in Table II and clearly  confirm the previous 
observations.  All HLA antisera  were successfully  inhibited,  regardless  of  their 
specificity,  as long as adequate amounts of  membranes of  Group A streptococci 
had  been added. In  contrast,  membranes from Group D streptococci  were much 
less  efficient.  Inhibition  was seen with only one B12 donor and these experi- 
ments could not be reproduced with target  cells  of another similar  donor.  In 
general,  the results  of  the Scandinavian method did  not differ  materially  from 
the results  obtained with the Terasaki method. 
These  findings  clearly  raised  the suspicion  that  nonspecific  inhibitory  mecha- 
nisms might be operative.  Fig. 1 gives a schematic view of the theoretical 
possibilities.  For  expression  of  direct  cytotoxicity  the  three  elements,  target  cell, 
specific  antibody, and C have to be granted free interaction  under suitable 
conditions.  Any interference  between these  three elements can lead  to abroga- 
tion of the cytotoxic  effect.  We decided to investigate  the two most likely 
nonspecific  mechanisms of  inhibition.  First~  evidence  by  other  investigators  had 
suggested that streptococcal  membrane fragments adhered to the surface of 
lyrnphocytes,  thereby masking or  sterically  blocking  HLA receptors  (6).  To test 
this  theory,  we modified the procedure as follows:  The target  cells  were incu- 
bated with antisera  before  addition  of  streptococcal  membranes and C. It  was 
hoped  that  the  blocking  effect  could  be  circumvented  by  this  technique.  If  so,  the 
theory of  the surface  effect  would become the most acceptable. 
The second hypothesis involves  the possibility  of  blocking cytotoxicity  via 
nonspecific  mechanisms, namely, the inactivation  of C. This phenomenon is J.  W.  TAUBER,  J.  A.  FALK,  R.  E.  FALK,  AND  J.  B.  ZABRISKIE  1345 
TABLE  II 
Effect of Streptococcal Antigens on the Lymphocyte Cytotoxicity Assay 
Antiserum  .................  A1  .  A2  A2  A2  B7  B12 
Lymphocyte donor  .........  0  /x  []  A  []  A  []  A  0  A  [] 
Streptococcal  None  ++++  ++++  ++++  ++++  ++++  ++++  ++÷+  ++++  ++++  +++  ++++ 
membranes 
(1.3mg/ml)  Group  A  .....  +  ..... 
Group  D  ++++  ++++  ++++  +++  ++++  +++  ++++  +++  ++  -  ++++ 
c), A1, B7; A, A1, B7, BI2; [], A2, A9, B12; ++++,  all cells dead; and -,  all cells alive. 
! 
t 
I  I  Ab  ,,, 
i 
I~G.  1.  A schematic representation of the possible sites of cytetexicity  inhibition by 
bacterial  antigens.  Each arrow includes  two alternatives.  The interference  between anti- 
body (Ab)  and  target  cell  could  occur  at  either  the  cell  surface  or  at  the  antibody-combining 
site.  The  interference  between C and  antibody  could  be  achieved  by  the  direct  attack  of  C or 
the  blocking  of  the  Fc portion  of  the antibody.  Ly,  lymphocyte. 
well known to serologists and has been observed with a variety of antigens, in 
particular with tissue extracts. To investigate this possibility, we decided to 
further modify our test system rather than to measure C consumption directly. 
Thus, we maintained the cytotoxicity system as such, but started with incuba- 
tion of C and streptococcal membranes before their addition to the cells and 
antisera.  The inhibitory effect was expected to  be  accentuated under these 
conditions since streptococcal membranes could interact with all available C 
before the introduction of competing cytotoxic immune complexes. The standard 
procedure and the above two modifications were carried out simultaneously and 
are reported as our second series. 
Determination of  Inhibitory Mechanisms.  The purpose of these experiments 
was to  differentiate between various nonspecific mechanisms of cytotoxicity 
inhibition. An exact outline of the suitably adapted modifications of the proce- 
dures is given in Table III. Special attention was given to the exact timing of  the 
addition of each component of the cytotoxic assay. The moment of adding the 
membranes  to the various other components  was felt  to be crucial and thus 
synchronized  as 0. This was done with the intention of avoiding any delay 
between sonication of the membranes  and assay of their activity. Thus, any 
observed difference could not be attributed to reaggregation of  membrane  flag- 
ments during waiting periods with consequent loss  of activity. 
Three HLA  antisera were tested with these three procedures. Doubling dilu- 1346  RE-EVALUATION  OF  HLA  CYTOTOXICITY  INHIBITION 
TABLE III 
Time Schedule and Modifications in the Sequence of  Addition of Various Components in 
Cytotoxicity Inhibition Studies 
Hours  I  II  III 
HLA-Ab*  HLA-Ab  HLA-Ab  C 
-  1  -  Ly$  -  - 
0  Membrane§  Membrane  Ly  Membrane 
1  Ly  C  Combined 
2  C  Read  Read 
3  Read  - 
* HLA-Ab, HLA antibody. 
* Ly, lymphocytes. 
§ Membrane, streptococcal membranes. 
tions were made up for this purpose reaching the end point of toxicity at titers of 
1:256. Each procedure was carried out with membranes of  Group A and Group D, 
as well as normal saline as a proper control. The results of  these experiments are 
depicted in  Fig.  2.  While all  experiments were carried out with membrane 
concentrations ranging from 7 to 250  ~g/ml, for the sake of clarity only two 
concentrations of membranes and one HLA antiserum (B7) were selected for 
depiction in the graphs.  The three columns refer to the three procedures as 
outlined on the top of the graphs (see Table III for details). The horizontal rows 
illustrate the experiments with the two concentrations of membrane (30 and 60 
~g indicated on the right side of the graph). Each individual graph gives the 
percent of dead cells on the ordinate and dilution of  the antiserum as a reciprocal 
on the abscissa. The stippled area represents the control run with normal saline, 
while the solid line gives the data after the addition of Group A membranes. The 
broken line refers to the effect produced by Group D membranes. 
If we consider the first column where the standard procedure was followed (I) 
in which antibody were incubated first with membranes, we can recognize that 
toxicity is neutralized at a titer of 1:32 with 60 ~g/ml membranes of Group A 
streptococci. Of interest was the consistent finding that Group D membranes 
appeared to enhance cytotoxicity rather than exerting a  blocking effect. All 
other concentrations of Group A membranes (from 7 to 250 ~g/ml) did not affect 
the cytotoxic reaction and indicated a rather narrow range of the membrane 
inhibitory effect. The dilution of the antiserum was also crucial.  Undiluted 
antisera did not emphasize the inhibitory effect of the membranes, while a 1:32 
dilution of the serum was completely inhibited. The inhibitory effect was lost 
with further dilutions, primarily on the basis of loss of  cytotoxicity  of  these weak 
HLA antisera. These variations only serve to underscore the value of testing all 
combinations of antisera dilutions and membrane concentrations. 
The second column evaluates the surface effect of streptococcal membranes. 
As indicated at the top of column II, antibody and target cells were mixed before 
streptococcal membranes would have a  chance to interfere with the reaction. 
Inhibition of cytotoxicity thus would be circumvented if the surface hypothesis 
were true. Quite in contrast, we see now that both Group A, as well as Group D J.  W.  TAUBER,  J.  A.  FALK,  R.  E.  FALK,  AND  J.  B.  ZABRISKIE  1347 
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FIG.  2.  Differentiation of the blocking mechanism. Normal cytotoxicity (stippled areas) of 
antiserum directed against HLA B7 is compared to the titers after addition of Group A (solid 
line) or Group D  (broken line) streptococcal membranes (m) in three different procedures 
(see Table IID. See the text for details of the experiment. Ab, antibody; Ly, lymphocytes; 
and recipe., reciprocals of titers. 
membranes,  are efficient blockers of cytotoxicity. This renders the theory of a 
surface effect untenable. 
In  the  third  column,  the  anticomplementary  hypothesis  is  tested.  C  and 
streptococcal membranes were incubated ahead of time as indicated on the top of 
this  column.  Here  we  can  readily  see  the  marked  inhibitory  effect  of the 
membranes on the cytotoxic assay. These results clearly favor the anticompli- 
mentary mechanism. At first glance, these results appear to be contradictory to 
those  obtained  when  Group  A  and  Group  D  membranes  were  mixed  with 
undiluted HLA antisera of known specificities (see Table ID. In the first set of 
experiments,  Group D  membranes  even at a  concentration  of 1.3 mg had no 
inhibitory  effect  on  the  cytotoxicity of known  HLA  antisera.  However the 
conditions of the two experiments were radically different. In the former tests 
undiluted  antisera  was  used  and  a  single  concentration  of membranes  em- 
ployed, while in the present set of experiments different concentrations of both 
membranes and antisera were combined in the system. Thus we can conclude 
that at certain concentrations of membrane and dilutions of serum, beth Group 
A  and  Group  D  membranes  are  effective inhibitors  of the  cytotoxicity test. 
However Group A membranes at all concentrations were more effective inhibi- 
tors of the system. 
Search for Specific Serological HLA Inhibition  Unrelated  to C  Consump- 
tion.  With the observation that the inhibitor of cytotoxicity was due to disturb- 
ance in C activity, a  search was made to circumvent the C effect. Accordingly, 
experiments  were designed to test the absorption effect of streptococcal mem- 
branes with HLA antisera before the addition of C to the assay system. It was 
therefore decided to absorb the HLA antisera first with these bacterial mem- 
branes.  After high speed centrifugation to eliminate all membrane fragments, 
the  clear  supernates  could  be  tested  for  remaining  toxicity.  In  detail,  the 1348  RE-EVALUATION  OF  HLA  CYTOTOXICITY  INHIBITION 
following protocol was observed: HLA antisora were incubated with Group A 
and Group D membranes, respectively, at 100 ~g/ml for 30 min at 37°C and in 
the cold overnight. The following day, the suspensions were centrifuged at 3,000 
g for 1 h in the cold and the supernates saved. A saline control was included for 
each  set  of experiments.  All  HLA  antisera  still  exhibited  specific toxicity 
against the appropriate target cells. Thus, no inhibition ofHLA cytotoxicity was 
observed when streptococcal membranes were incubated and then removed from 
HLA antisera. 
Cytotoxicity  Experiments  with  Group  A  Membrane Antisera.  While  our 
experiments failed  to  uncover any  relationship between these  streptococcal 
antigens and the known HLA antigens, it was still conceivable that the pre- 
sumed antigenic relationship was concerned with either HLA A  or B  of yet 
unknown specificity or to other gene products (HLA D) of the major histocom- 
patibility complex. It was therefore decided to test cross-reactivity via a reverse 
route: namely, to use antisera raised against streptococcal membranes in the 
classical cytotoxicity experiments. Accordingly, rabbits were immunized with 
membranes isolated from Group A  streptococcal strain T12/126/6.  These sera 
were shown to brightly stain sacolemmal membranes by the indirect fluores- 
cence technique  (19). Such sera  were then tested for cytotoxicity in  a  final 
dilution of 1:2 with PBS using the Terasaki procedure (14) (kindly carried out by 
M.  Fotino, Tissue Typing Laboratory,  New York Blood Center,  New York). 
Human lymphocytes from all HLA types and all major W specificities were used 
as target cells (Table IV). The results of these efforts clearly demonstrated that 
no toxicity was exerted by our antisera regardless of the specificities of target 
cells.  In addition, utilizing the  indirect fluorescence technique, no selective 
lymphocyte staining was achieved with antistreptococcal membrane antisera. 
Discussion 
The inhibition of cytotoxicity of HLA antisera observed in these studies is 
evidently not due to specific cross-reactions between HLA antigens and strepto- 
coccal membranes, but rather to the anticomplementary activity of the latter. 
How do our findings fit with the data reported by Hirata and Terasaki (5)? They 
have shown that extracts of type 1 M-protein inhibit HLA antisera specific to 
A1, A2, A3, Ag, B7,  and BS. Incubation of C with this soluble test substance 
alone for 1 h  before the addition of the lymphocytes decreased cytotoxicity by 
20% only. These authors concluded from these experiments that an anticomple- 
mentary effect of the test substance could not account for the observed inhibi- 
tion. However, their preincubation period is in a completely soluble system and 
is therefore not strictly comparable to the cytotoxicity assay where we always 
have a  solid phase secondary to the introduction of lymphocytes. Thus, the 
activity of these soluble extracts in the presence of a membrane surface (i.e., the 
lymphocyte membrane) cannot be excluded and remains a distinct possibility. 
Moreover, the formation of immune complexes of  M1 protein with antibody other 
than HLA antibody has not been excluded and could be responsible for the 
consumption of C with the corresponding nonspecific abolition of cytotoxicity. It 
has since been confirmed (20) that a variety of  gram-positive bacterial structures 
share such anticomplementary activity. In a subsequent report (20), this anti- J.  W.  TAUBER,  J.  A.  FALK,  R.  E.  FALK,  AND  J.  B.  ZABRISKIE  1349 
TABLE IV 
HLA Pattern of Target Cells Tested for Cytotoxicity with Antisera from Rabbits 
Immunized Against Group A  Streptococcal Membrane Strain T 12/126/6 
First series  Second series 
Mixture I  All, AW33, AW25  B13, B18, B27 
Mixture II  A2, A3  B7, B8, B12, BW15 
Mixture III  A1, A2  B12, BW10, B14, BW17 
Mixture IV  A9, AW30  B12, BWS, B18, BW22 
complementary activity has been identified as part of the alternate pathway. 
Factor D seems to play the key role in this activation, while neither properdin 
nor antibody are required. With respect to the data of Rapaport et al. (6), these 
authors have already suggested that nonserological, nonspecific mechanisms 
may be  responsible for the  observed cytotoxicity inhibition.  However,  they 
attribute the inhibition to binding of their material to the lymphocyte surface, 
thus sterically hindering cytotoxic effects of HLA antisera.  They also were 
unable to demonstrate an anticomplementary effect of their streptococcal prepa- 
ration but  the  use  of another  soluble  substance raises  the  same  questions 
presented by Hirata's experiments (see above). 
Unfortunately, the lack of evidence for specific cross-reactions between HLA 
antigens and streptococcal membranes is, in reality, a negative result and only 
seems to emphasize the disadvantages of such findings. It remains impossible to 
exclude such relationships entirely, moreover, because not all HLA specificities 
were tested and not all specificities are known. Indeed, numerous closely related 
products of the remaining major histocompatibility complex would have to be 
taken into consideration as well. However, these products are even less well 
defined and specific antisera are not yet available for all of these markers. 
Similar results were seen in the last series of experiments, in that we were 
unable to demonstrate cross-reactions using antistreptecoccal membrane anti- 
sera and a panel of lymphocytes. At least two interpretations of  these results are 
possible. First, in spite of the screening type of analysis used, we might have 
missed the appropriate specificity of the target cells again. Secondly, bacterial 
membranes are  heterogeneous antigens,  and the antibody might have been 
formed predominantly against haptenic determinants other than the ones sup- 
posed to relate to HLA antigens. 
We have formulated a  model of the immune system  2 which suggests that 
bacterial antigens would not (except under the rarest circumstances) be cross- 
reactive with our HLA antigens, and the findings reported here are at least 
compatible with this concept. This does not, however, detract from the bacte- 
rially induced homograft sensitization experiments of Rapaport and Chase (1), 
since this phenomenon  could be due to shared antigens related to the graft organ 
rather than the HLA antigens. In fact, mammalian antigens successfully mim- 
icked by bacteria, such as Group A streptococci, have all been shown to be organ 
related (22). From this, we can speculate that HLA markers might have evolved 
2 Tauber, J., E. C. Gotschlich, and J. B. Zabriskie. The T-cell receptor: evolution, supramolecu- 
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through selective evolutionary pressure as an escape from microbial mimicry. 
These markers would be characterized by a high genetic polymorphism so that 
their mimicry would fail to provide an epidemiological advantage for the invad- 
ing organism.  A  more detailed discussion of these general principles and con- 
cepts has been submitted elsewhere. 
Summary 
A number of experiments have suggested that there is an antigenic relation- 
ship between the HLA complex and streptococcal bacterial structures.  Using 
inhibition of cytotoxicity of HLA antisera as our assay system, it was demon- 
strated that the inhibitory effect on HLA cytotoxicity by streptococcal antigens 
is, in reality, due to activation and consumption of components of the alternate 
complement  pathway.  In  addition,  antisera  prepared  against  streptococcal 
membrane antigens had no cytotoxic effect on a large panel of human lympho- 
cytes, nor did these antisera exhibit immunofluorescent staining of lymphocytes 
directly.  These  experiments  are  compatible  with  our concept  that  the  HLA 
complex may have evolved through selective evolutionary pressure as a means 
of escaping bacterial mimicry. 
Pearl Pong contributed to these experiments with her supreme technical assistance. 
Received for publication 3 February 1976. 
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